FortifAI Raises AU$15 Million to Strengthen AI Growth Strategy.
FortifAI Limited (ASX: FTI) has successfully secured AU$15 million through a strategic placement, signalling strong investor backing for its growth plans. The capital was raised at AU$0.715 per share without any discount, indicating solid demand from institutional investors and confidence in the company’s direction. Approximately 20.98 million new shares will be issued, with completion expected in early May 2026. The proceeds will be used to advance Nol8 Technology, the company’s core AI platform designed to improve data processing efficiency and scalability. Additional funding will support marketing efforts, business development activities, and the expansion of existing operations, while also strengthening overall working capital. Nol8 leverages advanced algorithms and hardware acceleration to enable faster and more efficient data handling for complex AI systems. This funding positions FortifAI to accelerate innovation, expand partnerships, and enhance its competitive presence in the rapidly evolving artificial intelligence sector.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
FortifAI Raises AU$15 Million to Strengthen AI Growth Strategy.
FortifAI Limited (ASX: FTI) has successfully secured AU$15 million through a strategic placement, signalling strong investor backing for its growth plans. The capital was raised at AU$0.715 per share without any discount, indicating solid demand from institutional investors and confidence in the company’s direction. Approximately 20.98 million new shares will be issued, with completion expected in early May 2026. The proceeds will be used to advance Nol8 Technology, the company’s core AI platform designed to improve data processing efficiency and scalability. Additional funding will support marketing efforts, business development activities, and the expansion of existing operations, while also strengthening overall working capital. Nol8 leverages advanced algorithms and hardware acceleration to enable faster and more efficient data handling for complex AI systems. This funding positions FortifAI to accelerate innovation, expand partnerships, and enhance its competitive presence in the rapidly evolving artificial intelligence sector.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au